They “have no choice but to spend money on R&D if they wish to be in the pharmaceutical business,” she wrote in her 2004 book “The Truth About the Drug Companies.” Plenty of industries would kill to have net profit margins as healthy as major drug companies (blue columns) and generics makers (green).